Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Mycobacterium tuberculosis Modulates miR-106b-5p to Control Cathepsin S Expression Resulting in Higher Pathogen Survival and Poor T-Cell Activation.

Pires D, Bernard EM, Pombo JP, Carmo N, Fialho C, Gutierrez MG, Bettencourt P, Anes E.

Front Immunol. 2017 Dec 18;8:1819. doi: 10.3389/fimmu.2017.01819. eCollection 2017.

2.

Rab GTPases in Immunity and Inflammation.

Prashar A, Schnettger L, Bernard EM, Gutierrez MG.

Front Cell Infect Microbiol. 2017 Sep 29;7:435. doi: 10.3389/fcimb.2017.00435. eCollection 2017. Review.

3.

Molecular characterization of AfuFleA, an L-fucose-specific lectin from Aspergillus fumigatus.

Kuboi S, Ishimaru T, Tamada S, Bernard EM, Perlin DS, Armstrong D.

J Infect Chemother. 2013 Dec;19(6):1021-8. doi: 10.1007/s10156-013-0614-9. Epub 2013 May 22.

PMID:
23695231
4.

Fungal cell wall septation and cytokinesis are inhibited by bleomycins.

Moore CW, McKoy J, Del Valle R, Armstrong D, Bernard EM, Katz N, Gordon RE.

Antimicrob Agents Chemother. 2003 Oct;47(10):3281-9.

5.

Prospective study of Candida species in patients at a comprehensive cancer center.

Safdar A, Chaturvedi V, Cross EW, Park S, Bernard EM, Armstrong D, Perlin DS.

Antimicrob Agents Chemother. 2001 Jul;45(7):2129-33.

6.

Editorial

Armstrong D, Bernard EM.

Int J Infect Dis. 1998 Apr;2(4):181.

7.

Fluoroquinolone prophylaxis for the prevention of bacterial infections in patients with cancer--is it justified?

Murphy M, Brown AE, Sepkowitz KA, Bernard EM, Kiehn TE, Armstrong D.

Clin Infect Dis. 1997 Aug;25(2):346-8. No abstract available.

PMID:
9332551
8.

Antimicrobial activities of squalamine mimics.

Kikuchi K, Bernard EM, Sadownik A, Regen SL, Armstrong D.

Antimicrob Agents Chemother. 1997 Jul;41(7):1433-8.

10.

Efficacy of prophylactic aerosol amphotericin B lipid complex in a rat model of pulmonary aspergillosis.

Cicogna CE, White MH, Bernard EM, Ishimura T, Sun M, Tong WP, Armstrong D.

Antimicrob Agents Chemother. 1997 Feb;41(2):259-61.

11.

Induction of antibodies reactive with GM2 ganglioside after immunization with lipopolysaccharides from Camplyobacter jejuni.

Ritter G, Fortunato SR, Cohen L, Noguchi Y, Bernard EM, Stockert E, Old LJ.

Int J Cancer. 1996 Apr 10;66(2):184-90.

12.

Aerosol and parenteral pneumocandins are effective in a rat model of pulmonary aspergillosis.

Kurtz MB, Bernard EM, Edwards FF, Marrinan JA, Dropinski J, Douglas CM, Armstrong D.

Antimicrob Agents Chemother. 1995 Aug;39(8):1784-9.

13.

Restriction fragment length polymorphism analysis of clinical isolates of Mycobacterium haemophilum.

Kikuchi K, Bernard EM, Kiehn TE, Armstrong D, Riley LW.

J Clin Microbiol. 1994 Jul;32(7):1763-7.

14.

Activities of antimicrobial agents against clinical isolates of Mycobacterium haemophilum.

Bernard EM, Edwards FF, Kiehn TE, Brown ST, Armstrong D.

Antimicrob Agents Chemother. 1993 Nov;37(11):2323-6.

15.

Azithromycin, rifabutin, and rifapentine for treatment and prophylaxis of Mycobacterium avium complex in rats treated with cyclosporine.

Brown ST, Edwards FF, Bernard EM, Tong W, Armstrong D.

Antimicrob Agents Chemother. 1993 Mar;37(3):398-402.

16.

Pneumocystosis.

Bernard EM, Sepkowitz KA, Telzak EE, Armstrong D.

Med Clin North Am. 1992 Jan;76(1):107-19. Review.

PMID:
1727534
17.

Progressive disseminated infection with Mycobacterium avium complex after intravenous and oral challenge in cyclosporine-treated rats.

Brown ST, Edwards FF, Bernard EM, Niki Y, Armstrong D.

J Infect Dis. 1991 Nov;164(5):922-7.

PMID:
1940470
18.

Model of recurrent pulmonary aspergillosis in rats.

Niki Y, Bernard EM, Edwards FF, Schmitt HJ, Yu B, Armstrong D.

J Clin Microbiol. 1991 Jul;29(7):1317-22.

19.

Combination therapy in a model of pulmonary aspergillosis.

Schmitt HJ, Bernard EM, Edwards FF, Armstrong D.

Mycoses. 1991 Jul-Aug;34(7-8):281-5.

PMID:
1803227
20.

Pneumothorax in AIDS.

Sepkowitz KA, Telzak EE, Gold JW, Bernard EM, Blum S, Carrow M, Dickmeyer M, Armstrong D.

Ann Intern Med. 1991 Mar 15;114(6):455-9.

PMID:
1994791
21.

Human immunodeficiency virus (HIV)-associated pneumocystosis.

Armstrong D, Bernard EM.

Curr Clin Top Infect Dis. 1991;11:19-34. Review. No abstract available.

PMID:
1867767
22.

In vitro activity of the new semi-synthetic polypeptide cilofungin (LY121019) against Aspergillus and Candida species.

Huang A, Edwards F, Bernard EM, Armstrong D, Schmitt HJ.

Eur J Clin Microbiol Infect Dis. 1990 Sep;9(9):697-9.

PMID:
2226501
23.

Aerosolized pentamidine: effect on diagnosis and presentation of Pneumocystis carinii pneumonia.

Jules-Elysee KM, Stover DE, Zaman MB, Bernard EM, White DA.

Ann Intern Med. 1990 May 15;112(10):750-7.

PMID:
2331119
24.

Amphotericin B blunts erythropoietin response to anemia.

Lin AC, Goldwasser E, Bernard EM, Chapman SW.

J Infect Dis. 1990 Feb;161(2):348-51.

PMID:
2299214
25.

Pharmacokinetics of aerosol amphotericin B in rats.

Niki Y, Bernard EM, Schmitt HJ, Tong WP, Edwards FF, Armstrong D.

Antimicrob Agents Chemother. 1990 Jan;34(1):29-32.

26.

Aerosol amphotericin B is effective for prophylaxis and therapy in a rat model of pulmonary aspergillosis.

Schmitt HJ, Bernard EM, Häuser M, Armstrong D.

Antimicrob Agents Chemother. 1988 Nov;32(11):1676-9.

27.

A new bioassay for terbinafine.

Häuser M, Schmitt HJ, Bernard EM, Armstrong D.

Eur J Clin Microbiol Infect Dis. 1988 Aug;7(4):531-3.

PMID:
3141165
28.

Distribution of pentamidine in patients with AIDS.

Donnelly H, Bernard EM, Rothkotter H, Gold JW, Armstrong D.

J Infect Dis. 1988 May;157(5):985-9.

PMID:
3258901
29.

MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp.

Schmitt HJ, Bernard EM, Andrade J, Edwards F, Schmitt B, Armstrong D.

Antimicrob Agents Chemother. 1988 May;32(5):780-1.

30.

Distribution and activity of amphotericin B in humans.

Christiansen KJ, Bernard EM, Gold JW, Armstrong D.

J Infect Dis. 1985 Nov;152(5):1037-43.

PMID:
4045244
31.

Use of a new bioassay to study pentamidine pharmacokinetics.

Bernard EM, Donnelly HJ, Maher MP, Armstrong D.

J Infect Dis. 1985 Oct;152(4):750-4.

PMID:
4045230
32.

Evaluation of the Quantum II yeast identification system.

Kiehn TE, Edwards FF, Tom D, Lieberman G, Bernard EM, Armstrong D.

J Clin Microbiol. 1985 Aug;22(2):216-9.

33.

Stereoisomeric configuration of arabinitol in serum, urine, and tissues in invasive candidiasis.

Bernard EM, Wong B, Armstrong D.

J Infect Dis. 1985 Apr;151(4):711-5.

PMID:
3973418
34.

Catheter-associated fungemia caused by Fusarium chlamydosporum in a patient with lymphocytic lymphoma.

Kiehn TE, Nelson PE, Bernard EM, Edwards FF, Koziner B, Armstrong D.

J Clin Microbiol. 1985 Apr;21(4):501-4.

35.

Evaluation of the aldononitrile peracetate method for measuring arabinitol in serum.

Wong B, Bernard EM, Armstrong D, Roboz J, Suzuki R, Holland JF.

J Clin Microbiol. 1985 Mar;21(3):478-9. No abstract available.

36.
37.

Continuous high-grade mycobacterium avium-intracellulare bacteremia in patients with the acquired immune deficiency syndrome.

Wong B, Edwards FF, Kiehn TE, Whimbey E, Donnelly H, Bernard EM, Gold JW, Armstrong D.

Am J Med. 1985 Jan;78(1):35-40.

PMID:
3966486
38.

Serum arabinitol concentrations and arabinitol/creatinine ratios in invasive candidiasis.

Gold JW, Wong B, Bernard EM, Kiehn TE, Armstrong D.

J Infect Dis. 1983 Mar;147(3):504-13.

PMID:
6833796
39.

Synthesis of charged amphipathic nitroxide lipid spin labels and an example of their application in membrane studies.

Keana JF, Boyd SA, McMillen DA, Bernard EM, Jost PC.

Chem Phys Lipids. 1982 Dec;31(4):339-49.

PMID:
6297818
40.

Bone infection caused by debaryomyces hansenii in a normal host: a case report.

Wong B, Kiehn TE, Edwards F, Bernard EM, Marcove RC, de Harven E, Armstrong D.

J Clin Microbiol. 1982 Sep;16(3):545-8.

41.
42.

Increased arabinitol levels in experimental candidiasis in rats: arabinitol appearance rates, arabinitol/creatinine ratios, and severity of infection.

Wong B, Bernard EM, Gold JW, Fong D, Silber A, Armstrong D.

J Infect Dis. 1982 Sep;146(3):346-52.

PMID:
7050256
43.

Examination of Pseudomonas aeruginosa-gentamicin discrepancies encountered in an Autobac I-disk diffusion comparison.

Mayo JB, Kiehn TE, Wong B, Bernard EM, Armstrong D.

Antimicrob Agents Chemother. 1982 Mar;21(3):412-5.

44.

Rate of arabinitol production by pathogenic yeast species.

Bernard EM, Christiansen KJ, Tsang SF, Kiehn TE, Armstrong D.

J Clin Microbiol. 1981 Aug;14(2):189-94.

45.

Candidiasis: detection by gas-liquid chromatography of D-arabinitol, a fungal metabolite, in human serum.

Kiehn TE, Bernard EM, Gold JW, Armstrong D.

Science. 1979 Nov 2;206(4418):577-80.

PMID:
493963

Supplemental Content

Loading ...
Support Center